InsiderTrades

Form 4 for EW Edwards Lifesciences

Accepted 2022-03-11 00:00:00 ET · period of report 2022-03-11 · accession 0001225208-22-004575 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-03-11 2022-03-11 EW BOBO DONALD E JR CVP, Strategy, Corp Development S - Sale+OE $106.00 -11.1K 62.3K -15% -$1.17M
D 2022-03-11 2022-03-11 EW BOBO DONALD E JR CVP, Strategy, Corp Development M - OptEx $21.76 +11.1K 67.4K +20% +$240.4K
D 2022-03-11 2022-03-11 EW BOBO DONALD E JR CVP, Strategy, Corp Development M - OptEx $0.00 -11.1K 11.1K -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-03-11 S D 5,872 $105.63 56,399.40 D — — (F3) This transaction was executed in multiple trades at prices ranging from $105.08 to $106.01. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
2 Common Common Stock 2022-03-11 M A 11,050 $21.76 67,449.40 D — —
3 Common Common Stock 2022-03-11 S D 5,178 $106.42 62,271.40 D — — (F2) This transaction was executed in multiple trades at prices ranging from $106.08 to $106.81. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
4 Derivative Employee Stock Option (Right to Acquire) 2022-03-11 M D 11,050 $0.00 11,050 D $21.76 · 2016-05-14 to 2022-05-13 11,050 Common Stock